-
India’s Ranbaxy launches acne drug in US
Nov 26, 12 Drug NewsRanbaxy Laboratories Ltd, India’s top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc, said Ranbaxy, controlled by Japan’s Daiichi Sankyo Co, on Monday.
###
(Reuters)
Also in this section:
Subscribe to the "News" RSS Feed 
TOP ۞
